US HB444 | 2009-2010 | 111th Congress
Status
Spectrum: Moderate Partisan Bill (Democrat 85-18)
Status: Introduced on January 9 2009 - 25% progression, died in committee
Action: 2009-01-14 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on January 9 2009 - 25% progression, died in committee
Action: 2009-01-14 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
340B Program Improvement and Integrity Act of 2009 - Amends the Public Health Service Act to expand the drug discount program to allow participation as a covered entity by certain: (1) children's hospitals; (2) critical access hospitals; (3) entities providing maternal and child health services, community mental health services, or treatment services for substance abuse; (4) Medicare-dependent, small rural hospitals; (5) sole community hospitals; and (6) rural referral centers. Prohibits enrolled hospitals from obtaining covered outpatient drugs through a group purchasing arrangement. Requires the Secretary of Health and Human Services to establish reasonable exceptions to such requirements, including for drugs unavailable through the program and to facilitate generic substitution when a generic covered drug is available at a lower price. Expands the program to include a drug used in connection with an inpatient or outpatient service by enrolled hospitals. (Currently, only outpatient drugs are covered under the program.)Requires hospitals enrolled in the 340B drug discount program to provide to each state a credit on the estimated annual costs to such hospital of single source and innovator multiple source drugs and noninnovator multiple source drugs provided to Medicaid recipients for inpatient use. Sets forth a formula for calculating the credit. Allows a hospital to avoid paying such credits under certain circumstances. Requires the Secretary to: (1) carry out activities to improve compliance by manufacturers and covered entities with the requirements of the drug discount program; and (2) establish an administrative process for resolving claims by covered entities and manufacturers of violations of such requirements.Requires manufacturers to offer each covered entity covered drugs for purchase at or below the applicable ceiling price if such a drug is made available to any other purchaser at any price.
Title
340B Program Improvement and Integrity Act of 2009
Sponsors
History
Date | Chamber | Action |
---|---|---|
2009-01-14 | Referred to the Subcommittee on Health. | |
2009-01-09 | Referred to the House Committee on Energy and Commerce. |
Same As/Similar To
SB1239 (Related) 2009-06-11 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text of measure as introduced: CR S6546-6548)
Subjects
Administrative law and regulatory procedures
Administrative remedies
Child health
Consumer affairs
Department of Health and Human Services
Drug, alcohol, tobacco use
Government information and archives
Health
Health care costs and insurance
Health facilities and institutions
Hospital care
Medicaid
Medicare
Mental health
Poverty and welfare assistance
Prescription drugs
Rural conditions and development
Sex and reproductive health
Women's health
Administrative remedies
Child health
Consumer affairs
Department of Health and Human Services
Drug, alcohol, tobacco use
Government information and archives
Health
Health care costs and insurance
Health facilities and institutions
Hospital care
Medicaid
Medicare
Mental health
Poverty and welfare assistance
Prescription drugs
Rural conditions and development
Sex and reproductive health
Women's health
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/111th-congress/house-bill/444/all-info |
Text | https://www.congress.gov/111/bills/hr444/BILLS-111hr444ih.pdf |